Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BioStem TechnologiesBSEM -7.64%36 Market Cap is $64.2 Mil as of Aug. 11, 2026. GuruFocus rates BSEM with a GF Score™ of 36/100. The stock has 3 warning signs investors should review. Among 1,420 Biotechnology companies, BioStem Technologies ranks worse than 59.23% on this metric.
BioStem Technologies's quarterly market cap
increased
from Sep. 2024 ($162.2 Mil) to Dec. 2024 ($230.3 Mil) but then
declined
from Dec. 2024 ($230.3 Mil) to Sep. 2025 ($78.6 Mil).
BioStem Technologies's annual market cap
increased
from Dec. 2022 ($36.4 Mil) to Dec. 2023 ($95.0 Mil) and
increased
from Dec. 2023 ($95.0 Mil) to Dec. 2024 ($230.3 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. BioStem Technologies's Enterprise Value for Today is $40.4 Mil.
BioStem Technologies (NAS:BSEM) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
BioStem Technologies Market Cap Related Terms
BioStem Technologies Market Cap Historical Data
* Premium members only.
The historical data trend for BioStem Technologies's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, BioStem Technologies's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BioStem Technologies Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, BioStem Technologies's Market Cap distribution charts can be found below:
* The bar in red indicates where BioStem Technologies's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
BioStem Technologies's Market Cap for the fiscal year that ended in Dec. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BioStem Technologies (BSEM) has a Market Cap of $64.2 Mil as of Aug. 11, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on BioStem Technologies and its competitors. According to the industry distribution chart, BioStem Technologies ranks #841 out of 1420 companies in the Biotechnology industry, placing it in the top 59.2%.
Is BioStem Technologies' Market Cap too high?
BioStem Technologies' current Market Cap is $64.2 Mil. The Biotechnology industry median Market Cap is 116.29. BioStem Technologies' value of $64.2 Mil is 44.8% below this industry median. Based on the distribution chart, BioStem Technologies ranks #841 out of 1420 companies in the Biotechnology industry, which is below the industry midpoint. Overall, BioStem Technologies has a GF Score™ of 36/100, reflecting its overall financial health beyond just this single metric.
How does BioStem Technologies' Market Cap compare to RNTX and SPRO?
According to the Biotechnology industry distribution chart, BioStem Technologies ranks #841 out of 1420 companies for Market Cap. This places BioStem Technologies in the lower half of its industry. The industry median Market Cap is 116.29. BioStem Technologies' value of $64.2 Mil is 44.8% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 116.29, based on 1,420 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BioStem Technologies's current Market Cap of $64.2 Mil is 44.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on BioStem Technologies and its competitors. For the Biotechnology industry, the median Market Cap is 116.29 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BioStem Technologies's current Market Cap is $64.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioStem Technologies stock overvalued right now?
BioStem Technologies (BSEM) has a current Market Cap of $64.2 Mil. The current Market Cap is $64.2 Mil and 44.8% below the Biotechnology industry median of 116.29. BioStem Technologies' overall GF Score™ is 36/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For BioStem Technologies (BSEM), the current Market Cap is $64.2 Mil as of Aug. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
BioStem Technologies Inc is a regenerative biotechnology company focused on harnessing elements of perinatal tissue and the body's innate biology to repair or reverse damage caused by a broad range of degenerative diseases. The company develops, manufactures, and sells tissue allografts for the wound care market with a focus on the treatment of diabetic, pressure, and venous ulcers. Utilizing its proprietary BioRetain processing method, it manufactures perinatal tissue allografts. The company offers a comprehensive portfolio of high-quality brands that are trademarked and include VENDAJE AC, AmnioWrap2, and Others. The company generates key revenue from VENDAJE AC.
36GF Score
Get the complete analysis for BSEM
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSEM has been successfully added to your 
